Home301333 • SHE
add
R&G PharmaStudies Co Ltd
Previous close
¥60.15
Day range
¥58.48 - ¥60.40
Year range
¥33.05 - ¥73.08
Market cap
5.72B CNY
Avg Volume
1.95M
P/E ratio
46.77
Dividend yield
0.34%
Primary exchange
SHE
Market news
Financials
Income Statement
Revenue
Net income
(CNY) | Sep 2024info | Y/Y change |
---|---|---|
Revenue | 182.93M | 12.42% |
Operating expense | 43.14M | 77.18% |
Net income | 25.91M | -35.04% |
Net profit margin | 14.16 | -42.23% |
Earnings per share | — | — |
EBITDA | 26.88M | -31.32% |
Effective tax rate | 2.42% | — |
Balance Sheet
Total assets
Total liabilities
(CNY) | Sep 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.74B | 5.61% |
Total assets | 2.30B | 14.21% |
Total liabilities | 510.02M | 65.83% |
Total equity | 1.79B | — |
Shares outstanding | 94.56M | — |
Price to book | 3.19 | — |
Return on assets | 2.77% | — |
Return on capital | 3.39% | — |
Cash Flow
Net change in cash
(CNY) | Sep 2024info | Y/Y change |
---|---|---|
Net income | 25.91M | -35.04% |
Cash from operations | 44.35M | -48.87% |
Cash from investing | 147.94M | 132.23% |
Cash from financing | -24.68M | -730.29% |
Net change in cash | 165.60M | 144.07% |
Free cash flow | -62.97M | -232.03% |
About
Founded
Aug 22, 2008
Website
Employees
2,042